<SEC-DOCUMENT>0001628280-17-000870-index.html : 20170203
<SEC-HEADER>0001628280-17-000870.hdr.sgml : 20170203
<ACCEPTANCE-DATETIME>20170203170053
ACCESSION NUMBER:		0001628280-17-000870
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20170203
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20170203
DATE AS OF CHANGE:		20170203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		17572860

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k-acetadoteipupdate.htm
<DESCRIPTION>8-K - ACETADOTE IP UPDATE
<TEXT>
Document 1 - file: a8k-acetadoteipupdate.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-acetadoteupda.htm
<DESCRIPTION>EXHIBIT 99.1 - PRESS RELEASE - ACETADOTE UPDATE
<TEXT>
Document 2 - file: pressrelease-acetadoteupda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>updatedriskfactors.htm
<DESCRIPTION>EXHIBIT 99.2 UPDATED RISK DISCLOSURE
<TEXT>
Document 3 - file: updatedriskfactors.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cumberlanda02.gif
<TEXT>
Document 4 - file: cumberlanda02.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>cumberlanda08.jpg
<TEXT>
Document 5 - file: cumberlanda08.jpg

</DOCUMENT>
</SEC-DOCUMENT>